Beneficial effects of mangiferin on hyperlipidemia in high-fat-fed hamsters

Molecular Nutrition and Food Research

Volumn 55, Issue 12, 2011, Pages 1809-1818

  Guo, Fuchuan ^a   Huang, Conghui ^a   Liao, Xilu ^a   Wang, Yemei ^a   He, Ying ^a   Feng, Rennan ^a   Li, Ying ^a   Sun, Changhao ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Acyl CoA:diacylglycerol acyltransferase 2; Hamster; Hyperlipidemia; Mangiferin; Peroxisome proliferator activated receptor

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; ANTILIPEMIC AGENT; CARNITINE PALMITOYLTRANSFERASE; CARRIER PROTEIN; CD36 ANTIGEN; DIACYLGLYCEROL ACYLTRANSFERASE; FATTY ACID; LIPOPROTEIN LIPASE; MANGIFERIN; MESSENGER RNA; MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; TRIACYLGLYCEROL; XANTHONE DERIVATIVE;

ADIPOSE TISSUE; ANIMAL; ARTICLE; BLOOD; BODY WEIGHT; DOWN REGULATION; DRUG EFFECT; FAT INTAKE; GENETICS; HAMSTER; HYPERLIPIDEMIA; HYPERTRIGLYCERIDEMIA; LIPID DIET; LIPID METABOLISM; LIPOGENESIS; LIVER; MALE; METABOLISM; ORGAN SIZE; UPREGULATION;

ACETYL-COA CARBOXYLASE; ADIPOSE TISSUE; ANIMALS; ANTIGENS, CD36; BODY WEIGHT; CARNITINE O-PALMITOYLTRANSFERASE; CARRIER PROTEINS; CRICETINAE; DIACYLGLYCEROL O-ACYLTRANSFERASE; DIET, HIGH-FAT; DIETARY FATS; DOWN-REGULATION; FATTY ACIDS, NONESTERIFIED; HYPERLIPIDEMIAS; HYPERTRIGLYCERIDEMIA; HYPOLIPIDEMIC AGENTS; LIPID METABOLISM; LIPOGENESIS; LIPOPROTEIN LIPASE; LIVER; MALE; ORGAN SIZE; PPAR ALPHA; RNA, MESSENGER; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; TRIGLYCERIDES; UP-REGULATION; XANTHONES;

EID: 82955165824     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201100392     Document Type: Article

References (41)

1. Raza, J. A., Babb, J. D., Movahed, A., Optimal management of hyperlipidemia in primary prevention of cardiovascular disease. Int. J. Cardiol. 2004, 97, 355-366.
2. Watts, G. F., Karpe, F., Triglycerides and atherogenic dyslipidaemia: extending treatment beyond statins in the high-risk cardiovascular patient. Heart 2011, 97, 350-356.
3. Festi, D., Colecchia, A., Sacco, T., Bondi, M. et al., Hepatic steatosis in obese patients: clinical aspects and prognostic significance. Obes. Rev. 2004, 5, 27-42.
4. Maryniuk, M. D., Hyperlipidemia and diabetes: the role of dietary fats (continuing education credit). Diabetes Educ. 1989, 15, 258-265.
5. Lee, K. W., Bode, A. M., Dong, Z., Molecular targets of phytochemicals for cancer prevention. Nat. Rev. Cancer 2011, 11, 211-218.
6. Miura, T., Iwamoto, N., Kato, M., Ichiki, H. et al., The suppressive effect of mangiferin with exercise on blood lipids in type 2 diabetes. Biol. Pharm. Bull. 2001, 24, 1091-1092.
7. Prabhu, S., Jainu, M., Sabitha, K. E., Devi, C. S., Role of mangiferin on biochemical alterations and antioxidant status in isoproterenol-induced myocardial infarction in rats. J. Ethnopharmacol. 2006, 107, 126-133.
8. Garcia-Rivera, D., Delgado, R., Bougarne, N., Haegeman, G. et al., Gallic acid indanone and mangiferin xanthone are strong determinants of immunosuppressive anti-tumour effects of Mangifera indica L. bark in MDA-MB231 breast cancer cells. Cancer Lett. 2011, 305, 21-31.
9. Yoosook, C., Bunyapraphatsara, N., Boonyakiat, Y., Kantasuk, C., Anti-herpes simplex virus activities of crude water extracts of Thai medicinal plants. Phytomedicine 2000, 6, 411-419.
10. Leiro, J., Arranz, J. A., Yanez, M., Ubeira, F. M. et al., Expression profiles of genes involved in the mouse nuclear factor-kappa B signal transduction pathway are modulated by mangiferin. Int. Immunopharmacol. 2004, 4, 763-778.
11. Giron, M. D., Sevillano, N., Salto, R., Haidour, A. et al., Salacia oblonga extract increases glucose transporter 4-mediated glucose uptake in L6 rat myotubes: role of mangiferin. Clin. Nutr. 2009, 28, 565-574.
12. Huang, T. H., Peng, G., Li, G. Q., Yamahara, J. et al., Salacia oblonga root improves postprandial hyperlipidemia and hepatic steatosis in Zucker diabetic fatty rats: activation of PPAR-alpha. Toxicol. Appl. Pharmacol. 2006, 210, 225-235.
13. Muruganandan, S., Srinivasan, K., Gupta, S., Gupta, P. K. et al., Effect of mangiferin on hyperglycemia and atherogenicity in streptozotocin diabetic rats. J. Ethnopharmacol. 2005, 97, 497-501.
14. Folch, J., Lees, M., Sloane Stanley, G. H., A simple method for the isolation and purification of total lipides from animal tissues. J. Biol. Chem. 1957, 226, 497-509.
15. Liu, L., Li, Y., Guan, C., Li, K. et al., Free fatty acid metabolic profile and biomarkers of isolated post-challenge diabetes and type 2 diabetes mellitus based on GC-MS and multivariate statistical analysis. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 2010, 878, 2817-2825.
16. Miura, T., Nosaka, K., Ishii, H., Ishida, T., Antidiabetic effect of Nitobegiku, the herb Tithonia diversifolia, in KK-Ay diabetic mice. Biol. Pharm. Bull. 2005, 28, 2152-2154.
17. Castle, C. K., Colca, J. R., Melchior, G. W., Lipoprotein profile characterization of the KKA(y) mouse, a rodent model of type II diabetes, before and after treatment with the insulin-sensitizing agent pioglitazone. Arterioscler. Thromb. 1993, 13, 302-309.
18. Wei, M., Ong, L., Smith, M. T., Ross, F. B. et al., The streptozotocin-diabetic rat as a model of the chronic complications of human diabetes. Heart Lung Circ. 2003, 12, 44-50.
19. Keren, P., George, J., Shaish, A., Levkovitz, H. et al., Effect of hyperglycemia and hyperlipidemia on atherosclerosis in LDL receptor-deficient mice: establishment of a combined model and association with heat shock protein 65 immunity. Diabetes 2000, 49, 1064-1069.
20. Gao, S., He, L., Ding, Y., Liu, G., Mechanisms underlying different responses of plasma triglyceride to high-fat diets in hamsters and mice: roles of hepatic MTP and triglyceride secretion. Biochem. Biophys. Res. Commun. 2010, 398, 619-626.
21. Zhang, Z., Wang, H., Jiao, R., Peng, C. et al., Choosing hamsters but not rats as a model for studying plasma cholesterol-lowering activity of functional foods. Mol. Nutr. Food Res. 2009, 53, 921-930.
22. Martinez, I., Wallace, G., Zhang, C., Legge, R. et al., Diet-induced metabolic improvements in a hamster model of hypercholesterolemia are strongly linked to alterations of the gut microbiota. Appl. Environ. Microbiol. 2009, 75, 4175-4184.
23. Volek, J. S., Gomez, A. L., Love, D. M., Avery, N. G. et al., Effects of a high-fat diet on postabsorptive and postprandial testosterone responses to a fat-rich meal. Metabolism. 2001, 50, 1351-1355.
24. Browning, J. D., Horton, J. D., Molecular mediators of hepatic steatosis and liver injury. J. Clin. Invest. 2004, 114, 147-152.
25. Choi, C. S., Savage, D. B., Kulkarni, A., Yu, X. X. et al., Suppression of diacylglycerol acyltransferase-2 (DGAT2), but not DGAT1, with antisense oligonucleotides reverses diet-induced hepatic steatosis and insulin resistance. J. Biol. Chem. 2007, 282, 22678-22688.
26. Wang, Z., Yao, T., Song, Z., Involvement and mechanism of DGAT2 upregulation in the pathogenesis of alcoholic fatty liver disease. J. Lipid Res. 2010, 51, 3158-3165.
27. Qin, B., Anderson, R. A., Adeli, K., Tumor necrosis factor-alpha directly stimulates the overproduction of hepatic apolipoprotein B100-containing VLDL via impairment of hepatic insulin signaling. Am. J. Physiol. Gastrointest. Liver Physiol. 2008, 294, G1120-G1129.
28. Avramoglu, R. K., Adeli, K., Hepatic regulation of apolipoprotein B. Rev. Endocr. Metab. Disord. 2004, 5, 293-301.
29. Brown, M. S., Goldstein, J. L., The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell 1997, 89, 331-340.
30. Ikeda, S., Miyazaki, H., Nakatani, T., Kai, Y. et al., Up-regulation of SREBP-1c and lipogenic genes in skeletal muscles after exercise training. Biochem. Biophys. Res. Commun. 2002, 296, 395-400.
31. Nerurkar, P. V., Pearson, L., Efird, J. T., Adeli, K. et al., Microsomal triglyceride transfer protein gene expression and ApoB secretion are inhibited by bitter melon in HepG2 cells. J. Nutr. 2005, 135, 702-706.
32. Ferreira, A. V., Parreira, G. G., Porto, L. C., Mario, E. G. et al., Fenofibrate prevents orotic acid--induced hepatic steatosis in rats. Life Sci. 2008, 82, 876-883.
33. Nagatomo, F., Gu, N., Fujino, H., Takeda, I. et al., Skeletal muscle characteristics of rats with obesity, diabetes, hypertension, and hyperlipidemia. J. Atheroscler. Thromb. 2009, 16, 576-585.
34. Svegliati-Baroni, G., Candelaresi, C., Saccomanno, S., Ferretti, G. et al., A model of insulin resistance and nonalcoholic steatohepatitis in rats: role of peroxisome proliferator-activated receptor-alpha and n-3 polyunsaturated fatty acid treatment on liver injury. Am. J. Pathol. 2006, 169, 846-860.
35. Jeppesen, J., Albers, P. H., Rose, A. J., Birk, J. B. et al., Contraction-induced skeletal muscle FAT/CD36 trafficking and FA uptake is AMPK independent. J. Lipid Res. 2011, 52, 699-711.
36. Schreurs, M., Kuipers, F., van der Leij, F. R., Regulatory enzymes of mitochondrial beta-oxidation as targets for treatment of the metabolic syndrome. Obes. Rev. 2010, 11, 380-388.
37. Zhang, J., Wang, C., Terroni, P. L., Cagampang, F. R. et al., High-unsaturated-fat, high-protein, and low-carbohydrate diet during pregnancy and lactation modulates hepatic lipid metabolism in female adult offspring. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2005, 288, R112-R118.
38. Koonen, D. P., Jacobs, R. L., Febbraio, M., Young, M. E. et al., Increased hepatic CD36 expression contributes to dyslipidemia associated with diet-induced obesity. Diabetes 2007, 56, 2863-2871.
39. Lelliott, C. J., Ljungberg, A., Ahnmark, A., William-Olsson, L. et al., Hepatic PGC-1beta overexpression induces combined hyperlipidemia and modulates the response to PPARalpha activation. Arterioscler. Thromb. Vasc. Biol. 2007, 27, 2707-2713.
40. Harwood, H. J., Jr., Petras, S. F., Shelly, L. D., Zaccaro, L. M. et al., Isozyme-nonselective N-substituted bipiperidylcarboxamide acetyl-CoA carboxylase inhibitors reduce tissue malonyl-CoA concentrations, inhibit fatty acid synthesis, and increase fatty acid oxidation in cultured cells and in experimental animals. J. Biol. Chem. 2003, 278, 37099-37111.
41. Berk, E. S., Johnson, J. A., Lee, M., Zhang, K. et al., Higher post-absorptive skeletal muscle LPL activity in African American vs. non-Hispanic White pre-menopausal women. Obesity (Silver Spring) 2008, 16, 199-201.